White Oak Capital - Pharma and Healthcare Fund · Regular · Growth
NAV
₹15.1770
as of 17 Jun 2026
Expense Ratio
2.37%
AUM
₹524 Cr
Lumpsum returns (CAGR)
- 1Y
- +14.47%
- 3Y
- —
- 5Y
- —
- Since Inception
- +18.84%
SIP returns (XIRR)
- 1Y
- +18.95%
- 3Y
- —
- 5Y
- —
- Since Inception
- +16.99%
Returns calculated from 16 January 2024 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Beat the benchmark — ₹100/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹3,522
Benchmark
₹2,971
+₹551 extra wealth vs the benchmark index
Backtest this SIP yourselfSIP since inception — what ₹100/month became
Real NAV backtest from day one
₹2,900
Invested
₹3,522
Value today
17.1%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹500 lumpsum at launch — value today
Invested on the fund's first NAV date
₹500
Invested
₹759
Value today
19.0%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹8,27,058
Value today
-9.2%
vs lumpsum
Direct lumpsum would have beaten STP by 9.2% — but STP reduced timing risk
Model your own STP with real NAVRisk Metrics
Trailing 1 year, annualised0.23
Sharpe Ratio
+0.07
Alpha
0.37
Beta
0.21
Sortino
15.38%
Std Dev
-15.62%
Max Drawdown
Performance Comparison
Thinking about White Oak Capital - Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Investment Objective
White Oak Capital - Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
White Oak Capital - Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by WhiteOak Capital Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹524 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.37%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations